 Spandana Sphoorty Financial Ltd consolidated Q2FY26 loss at Rs. 249.13 crores
Spandana Sphoorty Financial Ltd consolidated Q2FY26 loss at Rs. 249.13 crores Steelcast Ltd posts higher PAT of Rs. 23.21 crores in Q2 FY26
Steelcast Ltd posts higher PAT of Rs. 23.21 crores in Q2 FY26 Schaeffler India Ltd Q3 CY2025 consolidated PAT up at Rs. 289.26 crores
Schaeffler India Ltd Q3 CY2025 consolidated PAT up at Rs. 289.26 crores Tatva Chintan Pharma Chem Ltd consolidated Q2FY26 PAT climbs to Rs. 9.91 crores
Tatva Chintan Pharma Chem Ltd consolidated Q2FY26 PAT climbs to Rs. 9.91 crores GPT Infraprojects Ltd receives contract worth Rs. 37.8 crore
GPT Infraprojects Ltd receives contract worth Rs. 37.8 crore 
              The equity shares of Plethico Pharmaceuticals Ltd (Scrip Code: 532739) will be listed and admitted to dealings on the Bombay Stock Exchange in the list of B1 Group Securities from May 05, 2006.
The equity shares of the Plethico Pharmaceuticals Limited (Symbol: PLETHICO) shall be listed and admitted to dealings on the National Stock Exchange w.e.f. May 05, 2006. Trading shall be in the Normal Market Segment - Compulsory Demat (Rolling Settlement) for all investors.